We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Organ-on-a-Chip Device Mimics Structure and Function of Human Placental Barrier

By LabMedica International staff writers
Posted on 09 Aug 2016
A novel lab-on-a-chip device mimics the structure and function of the human placental barrier and allows researchers to carry out in vitro studies on factors influencing fetal development.

During human pregnancy, the fetal circulation is separated from maternal blood in the placenta by two cell layers – the fetal capillary endothelium and placental trophoblast. More...
This placental barrier plays an essential role in fetal development and health by tightly regulating the exchange of endogenous and exogenous materials between the mother and the fetus.

To mimic the characteristic architecture of the human placental barrier, investigators at the University of Pennsylvania (Philadelphia, USA) created on a silicon chip a multilayered microfluidic system that enabled co-culture of human trophoblast cells and human fetal endothelial cells in a physiologically relevant spatial arrangement. The device comprised two parallel microfluidic channels separated by a porous membrane. On one side of those pores, trophoblast cells, which are found at the placental interface with maternal blood, were grown. On the other side were endothelial cells, found on the interior of fetal blood vessels.

The co-culture model was designed to induce progressive fusion of trophoblast cells and to form a syncytialized epithelium that resembled the in vivo syncytiotrophoblast. The system also allowed the cultured trophoblasts to form dense microvilli under dynamic flow conditions and to reconstitute expression and physiological localization of membrane transport proteins, such as glucose transporters (GLUTs), critical to the barrier function of the placenta.

In a proof-of-principle study, the investigators used the "placenta-on-a-chip" device to demonstrate physiological transport of glucose across the artificial maternal-fetal interface. They reported in the May 20, 2016, online edition of the journal Lab on a Chip that the rate of maternal-to-fetal glucose transfer in this system closely approximated that measured in ex vivo perfused human placentas.

"The placenta is arguably the least understood organ in the human body," said senior author Dr. Dongeun Huh, professor of bioengineering at the University of Pennsylvania, "and much remains to be learned about how transport between mother and fetus works at the tissue, cellular, and molecular levels. An isolated whole organ is not an ideal platform for these types of mechanistic studies. "

"The placental cells change over the course of pregnancy," said Dr. Huh. "During pregnancy, the placental trophoblast cells actually fuse with one another to form an interesting tissue called syncytium. The barrier also becomes thinner as the pregnancy progresses, and with our new model we are able to reproduce this change. Eventually, we hope to leverage the unique capabilities of our model to demonstrate the potential of organ-on-a-chip technology as a new strategy to innovate basic and translational research in reproductive biology and medicine."

Related Links:
University of Pennsylvania



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Drug Test Kit
DrugCheck 3000
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.